{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-06T06:35:46.700108+00:00","company":{"ticker":"MNOV","cik":1226616,"company_name":"MEDICINOVA INC"},"pagination":{"limit":100,"returned":2,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"7c23973b33908af341f802e12c5748ca693c3def","cik":1226616,"ticker":"MNOV","company_name":"MEDICINOVA INC","filed_at":"2025-12-30T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Sales Agreement","agreement_type":"atm_program","counterparty":"Lucid Capital Markets, LLC","effective_date":"2025-12-29","item_codes_triggered":["1.01"],"value_text":"$50,000,000"},"claim":"MEDICINOVA INC entered into Sales Agreement with Lucid Capital Markets, LLC valued at $50,000,000 (effective 2025-12-29).","evidence_excerpt":"On December 29, 2025, MediciNova, Inc. (the “Company”) entered into an equity distribution agreement with Lucid Capital Markets, LLC (“Agent”) to sell shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), from time to time through the Agent, acting as sales agent, having a maximum aggregate offering price of $50,000,000 (the “Sales Agreement”).","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001193125-25-335917","anchor_url":"https://secwatch.observer/filing/0001193125-25-335917#claim-7c23973b33908af341f802e12c5748ca693c3def","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1226616/000119312525335917/0001193125-25-335917-index.htm"},{"fact_type":"executive_change","fact_key":"65a00fcfe3","cik":1226616,"ticker":"MNOV","company_name":"MEDICINOVA INC","filed_at":"2024-04-01T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-04-02","interim":false,"role":"Vice President","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Geoffrey O'Brien resigned as Vice President at MEDICINOVA INC.","evidence_excerpt":"On March 26, 2024, Geoffrey O’Brien informed MediciNova, Inc. (the “Company”) of his decision to retire from full-time employment and resign from his employment with the Company, effective as of April 2, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-083356","anchor_url":"https://secwatch.observer/filing/0001193125-24-083356#claim-65a00fcfe3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1226616/000119312524083356/0001193125-24-083356-index.htm"}]}